NanoViricides
NNVC
#10132
Rank
ยฃ16.61 M
Marketcap
ยฃ0.92
Share price
0.82%
Change (1 day)
-19.31%
Change (1 year)

Earnings for NanoViricides (NNVC)

Earnings in 2025 (TTM): -ยฃ7.2 Million

According to NanoViricides's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -ยฃ7.03 Million a decrease over its 2023 earnings that were of -ยฃ7.03 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for NanoViricides from 2007 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ7.2 Million2.36%
2024 -ยฃ7.03 Million0.09%
2023 -ยฃ7.03 Million35.83%
2022 -ยฃ5.18 Million-20.96%
2021 -ยฃ6.55 Million-40.3%
2020 -ยฃ10.96 Million86.2%
2019 -ยฃ5.89 Million0.09%
2018 -ยฃ5.89 Million-25.39%
2017 -ยฃ7.89 Million-6.68%
2016 -ยฃ8.45 Million114.25%
2015 -ยฃ3.95 Million-5.43%
2014 -ยฃ4.17 Million-59.73%
2013 -ยฃ10.36 Million106.16%
2012 -ยฃ5.03 Million5.57%
2011 -ยฃ4.76 Million6.42%
2010 -ยฃ4.47 Million93.61%
2009 -ยฃ2.31 Million-4.07%
2008 -ยฃ2.41 Million19.12%
2007 -ยฃ2.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
BioCryst Pharmaceuticals
BCRX
-ยฃ4.97 Million-30.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
ยฃ0.28 B-4,061.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ7.42 B-104,526.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ6.02 B-84,952.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ17.33 B-244,000.64%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ6.99 B-98,578.18%๐Ÿ‡ฌ๐Ÿ‡ง UK